FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1925087632> ?p ?o ?g. }

• W1925087632 endingPage "83" @default.
• W1925087632 startingPage "5073" @default.
• W1925087632 abstract "An antagonistic monoclonal antibody, designated EM164, has been developed which binds specifically to the human insulin-like growth factor I receptor (IGF-IR) and inhibits the proliferation and survival functions of the receptor in cancer cells. EM164 was initially selected by a rapid cell-based screen of hybridoma supernatants to identify antibodies that bind to IGF-IR but not to the homologous insulin receptor and that show maximal inhibition of IGF-I-stimulated autophosphorylation of IGF-IR. EM164 binds tightly to IGF-IR with a dissociation constant K(d) of 0.1 nM, inhibits binding of IGF-I and antagonizes its effects on cells completely, and has no agonistic activity on its own. EM164 inhibits IGF-I-, IGF-II-, and serum-stimulated proliferation and survival of diverse human cancer cell lines in vitro, including breast, lung, colon, cervical, ovarian, pancreatic, melanoma, prostate, neuroblastoma, rhabdomyosarcoma, and osteosarcoma cancer lines. It also suppresses the autocrine or paracrine proliferation of several cancer cell lines. EM164 was the most potent antagonistic anti-IGF-IR antibody tested when compared with several commercially available antibodies. The in vitro inhibitory effect could be extended to in vivo tumor models, where EM164 caused regression of established BxPC-3 human pancreatic tumor xenografts in SCID mice. The antitumor effect of treatment with EM164 could be enhanced by combining it with the cytotoxic agent gemcitabine. These data support the development of EM164 as a candidate therapeutic agent that targets IGF-IR function in cancer cells." @default.
• W1925087632 created "2016-06-24" @default.
• W1925087632 creator A5019736122 @default.
• W1925087632 creator A5044927421 @default.
• W1925087632 creator A5046139499 @default.
• W1925087632 creator A5059649022 @default.
• W1925087632 creator A5069045025 @default.
• W1925087632 creator A5073832605 @default.
• W1925087632 creator A5076101275 @default.
• W1925087632 creator A5076481413 @default.
• W1925087632 creator A5086712201 @default.
• W1925087632 date "2003-08-15" @default.
• W1925087632 modified "2023-10-12" @default.
• W1925087632 title "An anti-insulin-like growth factor I receptor antibody that is a potent inhibitor of cancer cell proliferation." @default.
• W1925087632 cites W1488956616 @default.
• W1925087632 cites W1492411710 @default.
• W1925087632 cites W1505531110 @default.
• W1925087632 cites W1529872233 @default.
• W1925087632 cites W1531521114 @default.
• W1925087632 cites W1532840646 @default.
• W1925087632 cites W1533129085 @default.
• W1925087632 cites W1542569743 @default.
• W1925087632 cites W1583743328 @default.
• W1925087632 cites W1584184269 @default.
• W1925087632 cites W1590353710 @default.
• W1925087632 cites W1591360311 @default.
• W1925087632 cites W1594700207 @default.
• W1925087632 cites W1675602016 @default.
• W1925087632 cites W1931843124 @default.
• W1925087632 cites W1932606735 @default.
• W1925087632 cites W1954313480 @default.
• W1925087632 cites W1969898679 @default.
• W1925087632 cites W1970285990 @default.
• W1925087632 cites W1972486056 @default.
• W1925087632 cites W1980271442 @default.
• W1925087632 cites W1985832060 @default.
• W1925087632 cites W1998149673 @default.
• W1925087632 cites W2000111014 @default.
• W1925087632 cites W2002052645 @default.
• W1925087632 cites W2006754781 @default.
• W1925087632 cites W2009876678 @default.
• W1925087632 cites W2013523350 @default.
• W1925087632 cites W2017965947 @default.
• W1925087632 cites W2020636054 @default.
• W1925087632 cites W2023676204 @default.
• W1925087632 cites W2029863620 @default.
• W1925087632 cites W2062860025 @default.
• W1925087632 cites W2064209392 @default.
• W1925087632 cites W2066293358 @default.
• W1925087632 cites W2074465644 @default.
• W1925087632 cites W2088906557 @default.
• W1925087632 cites W2089793026 @default.
• W1925087632 cites W2094385634 @default.
• W1925087632 cites W2094476084 @default.
• W1925087632 cites W2094627540 @default.
• W1925087632 cites W2098544382 @default.
• W1925087632 cites W2098547168 @default.
• W1925087632 cites W2100937050 @default.
• W1925087632 cites W2104135564 @default.
• W1925087632 cites W2115737887 @default.
• W1925087632 cites W2116393840 @default.
• W1925087632 cites W2117350664 @default.
• W1925087632 cites W2127526484 @default.
• W1925087632 cites W2133825351 @default.
• W1925087632 cites W2137217845 @default.
• W1925087632 cites W2138762676 @default.
• W1925087632 cites W2144683616 @default.
• W1925087632 cites W2145789538 @default.
• W1925087632 cites W2147114673 @default.
• W1925087632 cites W2148527073 @default.
• W1925087632 cites W2150081825 @default.
• W1925087632 cites W2152776758 @default.
• W1925087632 cites W2156807752 @default.
• W1925087632 cites W2158193323 @default.
• W1925087632 cites W2159318197 @default.
• W1925087632 cites W2160466713 @default.
• W1925087632 cites W2160835537 @default.
• W1925087632 cites W2166091439 @default.
• W1925087632 cites W2166585583 @default.
• W1925087632 cites W2169332099 @default.
• W1925087632 cites W2395278466 @default.
• W1925087632 cites W7405620 @default.
• W1925087632 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12941837" @default.
• W1925087632 hasPublicationYear "2003" @default.
• W1925087632 type Work @default.
• W1925087632 sameAs 1925087632 @default.
• W1925087632 citedByCount "83" @default.
• W1925087632 countsByYear W19250876322012 @default.
• W1925087632 countsByYear W19250876322013 @default.
• W1925087632 countsByYear W19250876322014 @default.
• W1925087632 countsByYear W19250876322015 @default.
• W1925087632 countsByYear W19250876322016 @default.
• W1925087632 countsByYear W19250876322017 @default.
• W1925087632 countsByYear W19250876322018 @default.
• W1925087632 countsByYear W19250876322019 @default.
• W1925087632 countsByYear W19250876322021 @default.
• W1925087632 crossrefType "journal-article" @default.
• W1925087632 hasAuthorship W1925087632A5019736122 @default.

• next